Robert B Jenkins

Robert B Jenkins

UNVERIFIED PROFILE

Are you Robert B Jenkins?   Register this Author

Register author
Robert B Jenkins

Robert B Jenkins

Publications by authors named "Robert B Jenkins"

Are you Robert B Jenkins?   Register this Author

100Publications

4118Reads

49Profile Views

Working Up Group 4 Equivocal HER2 Samples Tested by Fluorescence in Situ Hybridization in a Reference Laboratory Setting: Past, Present, and Future.

J Clin Oncol 2020 Jan 26;38(2):175-176. Epub 2019 Nov 26.

Katherine B. Geiersbach, MD; Reid G. Meyer; Daniel R. Sill; Taofic Mounajjed, MD; Beiyun Chen, MD, PhD; William R. Sukov, MD; and Robert B. Jenkins, MD, PhD, Mayo Clinic School of Medicine, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.02482DOI Listing
January 2020

Plenty of calcification: imaging characterization of polymorphous low-grade neuroepithelial tumor of the young.

Neuroradiology 2019 Nov 9;61(11):1327-1332. Epub 2019 Aug 9.

Department of Radiology, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00234-019-02269-yDOI Listing
November 2019

Desmoplastic Infantile Ganglioglioma: A MAPK Pathway-Driven and Microglia/Macrophage-Rich Neuroepithelial Tumor.

J Neuropathol Exp Neurol 2019 Nov;78(11):1011-1021

Departments of Laboratory Medicine and Pathology, Health Sciences Research, Pediatrics, Radiation Oncology, and Neurologic Surgery, Mayo Clinic, Rochester, Minnesota; and Departments of Pathology and Neuro-Oncology, Dell Children's Medical Center, Austin, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnen/nlz086DOI Listing
November 2019

Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior.

J Neuropathol Exp Neurol 2019 Sep;78(9):791-797

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnen/nlz064DOI Listing
September 2019

Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer's disease brain.

Nanomedicine 2019 02 6;16:258-266. Epub 2018 Oct 6.

Department of Pharmaceutics and Brain Barriers Research Center, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA; Molecular Neurobiology Laboratory, Departments of Neurology, Neuroscience and Biochemistry/Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nano.2018.09.010DOI Listing
February 2019

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

Arch Pathol Lab Med 2018 11 30;142(11):1364-1382. Epub 2018 May 30.

Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland; Lisa M. McShane, National Cancer Institute, Bethesda, Maryland; M. Elizabeth Hale Hammond, Intermountain Healthcare and University of Utah School of Medicine, Salt Lake City; Kimberly H. Allison, Stanford University School of Medicine, Stanford, California; Patrick Fitzgibbons, St Jude Medical Center, Fullerton, California; Michael F. Press, University of Southern California, Los Angeles; Brittany E. Harvey and Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, Virginia; John M.S. Bartlett, Ontario Institute for Cancer Research, Toronto, Ontario, Canada; Wedad Hanna, Sunnybrook Health Sciences Centre and Women's College Hospital, Toronto, Ontario, Canada; Michael Bilous, Western Sydney University and Australian Clinical Laboratories, Sydney, Australia; Ian O. Ellis, The University of Nottingham, Nottingham, United Kingdom; Mitchell Dowsett, The Royal Marsden NHS Foundation Trust, London, United Kingdom; Robert B. Jenkins, Mayo Clinic, Rochester, Minnesota; Patricia A. Spears, Cancer Information and Support Network, Raleigh, North Carolina; Gail H. Vance, Indiana University School of Medicine, Indianapolis; and Giuseppe Viale, University of Milan and Istituto Europeo di Oncologia, Milan, Italy.

View Article

Download full-text PDF

Source
http://www.archivesofpathology.org/doi/10.5858/arpa.2018-090
Publisher Site
http://dx.doi.org/10.5858/arpa.2018-0902-SADOI Listing
November 2018

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

J Clin Oncol 2018 07 30;36(20):2105-2122. Epub 2018 May 30.

Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore; Lisa M. McShane, National Cancer Institute, Bethesda, MD; M. Elizabeth Hale Hammond, Intermountain Healthcare and University of Utah School of Medicine, Salt Lake City, UT; Kimberly H. Allison, Stanford University School of Medicine, Stanford; Patrick Fitzgibbons, St Jude Medical Center, Fullerton; Michael F. Press, University of Southern California, Los Angeles, CA; Brittany E. Harvey and Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; John M.S. Bartlett, Ontario Institute for Cancer Research; Wedad Hanna, Sunnybrook Health Sciences Centre and Women's College Hospital, Toronto, Ontario, Canada; Michael Bilous, Western Sydney University and Australian Clinical Laboratories, Sydney, New South Wales, Australia; Ian O. Ellis, The University of Nottingham, Nottingham; Mitchell Dowsett, The Royal Marsden NHS Foundation Trust, London, United Kingdom; Robert B. Jenkins, Mayo Clinic, Rochester, MN; Patricia A. Spears, Cancer Information and Support Network, Raleigh, NC; Gail H. Vance, Indiana University School of Medicine, Indianapolis, IN; and Giuseppe Viale, University of Milan and Istituto Europeo di Oncologia, Milan, Italy.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.77.8738
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.77.8738DOI Listing
July 2018

Development and Verification of an RNA Sequencing (RNA-Seq) Assay for the Detection of Gene Fusions in Tumors.

J Mol Diagn 2018 07 19;20(4):495-511. Epub 2018 Jun 19.

Department of Laboratory Medicine and Pathology, Divisions of Laboratory Genetics and Experimental Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2018.03.007DOI Listing
July 2018

SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq).

Cancer Genet 2018 02 2;221:1-18. Epub 2017 Dec 2.

Center for Individualized Medicine-Biomarker Discovery, Mayo Clinic, Rochester MN, USA; Department of Molecular Medicine, Mayo Clinic, Rochester MN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2017.11.009DOI Listing
February 2018

Giant Cell Ependymoma of Lateral Ventricle: Case Report, Literature Review, and Analysis of Prognostic Factors and Genetic Profile.

World Neurosurg 2017 Dec 21;108:997.e9-997.e14. Epub 2017 Sep 21.

Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2017.09.088DOI Listing
December 2017

Radiogenomics to characterize regional genetic heterogeneity in glioblastoma.

Neuro Oncol 2017 01 8;19(1):128-137. Epub 2016 Aug 8.

Department of Radiology, Mayo Clinic, Phoenix, Arizona (L.S.H., T.W., J.M.H.); Department of Biostatistics, Mayo Clinic, Phoenix, Arizona (A.C.D.); Department of Research, Mayo Clinic, Arizona (J.R.M., K.S.); Department of Neurosurgery, Mayo Clinic, Phoenix, Arizona (K.R.S.); Department of Cancer and Cell Biology, Mayo Clinic, Scottsdale, Arizona (J.C.L.); Department of Pathology, Mayo Clinic, Rochester, Minnesota (R.B.J., T.M.K.); Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota (H.S.); Department of Neuro-oncology, Mayo Clinic, Rochester, Minnesota (B.P.O.); Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota (J.S.); Department of Pharmaceutics, University of Minnesota, Minneapolis, Minnesota (W.E.); Department of Cancer and Cell Biology, Translational Genomics Research Institute, Phoenix, Arizona (S.P., N.L.T.); School of Computing, Informatics and Decision Systems Engineering, Arizona State University, Tempe, Arizona (J.L., T.W., S.N., N.G.); Department of Biomedical Informatics, Arizona State University, Tempe, Arizona (S.R.); School of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona (J.P., D.F.); Department of Pathology, Barrow Neurological Institute - St. Joseph's Hospital and Medical Center, Phoenix, Arizona (J.M.E.); Department of Neurosurgery, Barrow Neurological Institute - St. Joseph's Hospital and Medical Center, Phoenix, Arizona (K.A.S., P.N.); Department of Radiology, Barrow Neurological Institute - St. Joseph's Hospital and Medical Center, Phoenix, Arizona (L.C.B., J.P. K., L.S.H.); Department of Imaging Research, Barrow Neurological Institute - St. Joseph's Hospital and Medical Center, Phoenix, Arizona (C.C.Q.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193022PMC
January 2017

Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists Guidelines.

J Clin Oncol 2016 10;34(29):3502-3510

Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer, Kathleen S. Tenner, Karla V. Ballman, Stefan J, Green, William R. Sukov, Rhett P. Ketterling, Robert B. Jenkins, Mayo Clinic, Rochester, MN; and Edith A. Perez, Mayo Clinic, Jacksonville, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.8983DOI Listing
October 2016

Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma.

J Natl Cancer Inst 2016 May 27;108(5). Epub 2015 Nov 27.

Department of Radiation Oncology (SKG, BLC, ACM, KKB, JLP, MAS, LC, GJK, JNS), Division of Medical Oncology (SHK), Molecular Pharmacology and Experimental Therapeutics (FBA, JMR), Division of Biomedical Statistics and Informatics (PAD, JEEP, KVB), and Laboratory Medicine and Pathology (GS, RBJ), Mayo Clinic, Rochester MN; The University of Texas, MD Anderson Cancer Center, Houston, TX (RGV, EPS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv369DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862419PMC
May 2016

Statistical considerations on prognostic models for glioma.

Neuro Oncol 2016 05 8;18(5):609-23. Epub 2015 Dec 8.

Department of Neurological Surgery, University of California San Francisco (UCSF), San Francisco, California (A.M.M., M.R.W.); Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California (A.M.M., M.R.W.); Institute of Human Genetics, University of California San Francisco, San Francisco, California (M.R.W.); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (R.B.J.); Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota (J.E.E.-P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov255DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827041PMC
May 2016

AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth.

Prostate 2016 May 15;76(6):597-608. Epub 2016 Jan 15.

Division of Medical Oncology, Department of Medicine, University of Southern California Keck School of Medicine and Translational and Clinical Science Program, USC Norris Comprehensive Cancer Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23151DOI Listing
May 2016

A Rare Pediatric Example of Subcutaneous Extraskeletal Osteosarcoma: A Case Report and Review of the Morphologic Differential Diagnosis.

Am J Dermatopathol 2016 Apr;38(4):e44-8

Departments of *Laboratory Medicine and Pathology, and †Orthopedic Surgery, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DAD.0000000000000458DOI Listing
April 2016

Understanding inherited genetic risk of adult glioma - a review.

Neurooncol Pract 2016 Mar 25;3(1):10-16. Epub 2015 Aug 25.

Division of Neuroepidemiology, Department of Neurological Surgery , University of California , San Francisco, 1450 3rd Street, San Francisco, CA 94158 (T.R., A.M.M., K.M.W, S.S.F., J.W., J.K.W., M.R.W.); Department of Laboratory Medicine and Pathology , Mayo Clinic College of Medicine , 200 First Street SW, Rochester, MN 55905 (D.H.L., R.B.J.); Department of Neurology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905 (D.H.L.) ; Department of Epidemiology and Biostatistics , University of California , San Francisco, 1450 3rd Street, San Francisco, CA 94158 (A.M.M., J.W.); Division of Biomedical Statistics and Informatics , Mayo Clinic College of Medicine , 200 First Street SW, Rochester, MN 55905 (J.E.E.-P.); Program in Cancer Genetics, Helen Diller Family Comprehensive Cancer Center , University of California , San Francisco, 1450 3rd Street, San Francisco, CA 94158 (K.M.W., J.W., J.K.W., M.R.W.); Case Comprehensive Cancer Center , Case Western Reserve University School of Medicine , 11100 Euclid Avenue, Cleveland, OH 44106-5065 (J.B.-S., Q.T.O.); Central Brain Tumor Registry of the United States , 244 East Ogden Ave Suite 116, Hinsdale, IL 60521 (J.B.-S., Q.T.O.).

View Article

Download full-text PDF

Source
https://academic.oup.com/nop/article-lookup/doi/10.1093/nop/
Publisher Site
http://dx.doi.org/10.1093/nop/npv026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774334PMC
March 2016

Telomere maintenance and the etiology of adult glioma.

Neuro Oncol 2015 Nov 25;17(11):1445-52. Epub 2015 May 25.

Department of Neurological Surgery, University of California-San Francisco, San Francisco, California (K.M.W., J.K.W., A.M.M., M.R.W.); Institute for Human Genetics, University of California-San Francisco, San Francisco, California (J.K.W., M.R.W.); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (D.H.L., R.B.J.); Department of Neurology, Mayo Clinic, Rochester, Minnesota (D.H.L.); Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California (J.L.W., A.M.M.); Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota (J.E.E.-P.).

View Article

Download full-text PDF

Source
http://neuro-oncology.oxfordjournals.org/content/17/11/1445.
Web Search
http://neuro-oncology.oxfordjournals.org/lookup/doi/10.1093/
Publisher Site
http://dx.doi.org/10.1093/neuonc/nov082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648301PMC
November 2015

A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution.

Cancer Res 2015 Nov 2;75(22):4884-94. Epub 2015 Nov 2.

Division of Neuroepidemiology, Department of Neurological Surgery, University of California, San Francisco, San Francisco, California. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California. Institute for Human Genetics, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/early/2015/11/01/0
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-15-1105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651745PMC
November 2015

Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.

Eur Urol 2015 Oct 8;68(4):555-67. Epub 2015 May 8.

Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.04.033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562381PMC
October 2015

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.

N Engl J Med 2015 Jun 10;372(26):2499-508. Epub 2015 Jun 10.

From the Departments of Health Sciences Research (J.E.E.-P., P.A.D., H.S., M.L.K.), Laboratory Medicine and Pathology (D.H.L., G.S., A.A.C., T.M.K., C.E.P., A.R.C., C.H., C.G., R.B.J.), Neurology (D.H.L., B.P.O.), and Oncology (J.C.B.), Mayo Clinic, Rochester, MN; the Departments of Neurological Surgery (A.M.M., K.M.W., T.R., I.V.S., H.M.H., L.S.M., S.Z., A.P., M.S.B., S.M.C., M.D.P., J.K.W., M.R.W.), Epidemiology and Biostatistics (A.M.M., P.M.B., J.W., J.K.W., M.R.W.) and Pathology (M.P., R.M., G.F.R., A.P., T.T.) and the Institute of Human Genetics (J.W., J.K.W., M.R.W.), University of California, San Francisco, and the Bioinformatics Core, Gladstone Institutes (A.R.P.) - all in San Francisco; and the Department of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York (J.T.H.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1407279
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1407279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489704PMC
June 2015

Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.

J Clin Oncol 2015 Mar 20;33(7):701-8. Epub 2015 Jan 20.

Edith A. Perez, E. Aubrey Thompson, Yan W. Asmann, and Xochiquetzal J. Geiger, Mayo Clinic, Jacksonville, FL; Karla V. Ballman, S. Keith Anderson, Krishna R. Kalari, Jeanette E. Eckel-Passow, Kathleen S. Tenner, Jin Jen, Beiyun Chen, Robert B. Jenkins, and Monica M. Reinholz, Mayo Clinic, Rochester, MN; Amylou C. Dueck, and Ann E. McCullough, Mayo Clinic, Scottsdale, AZ; Jian-Bing Fan, Illumina, San Diego, CA; George W. Sledge, Stanford School of Medicine, Palo Alto, CA; Eric P. Winer, Harvard Medical School, Boston, MA; and Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.6298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334774PMC
March 2015

Germline mutations in shelterin complex genes are associated with familial glioma.

J Natl Cancer Inst 2015 Jan 7;107(1):384. Epub 2014 Dec 7.

Affiliations of authors: Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX (MNB, SNJ, HD, LL, JT, DMM, RAG); Codified Genomics, LLC, Houston, TX (MNB); Department of Pediatrics, Division of Hematology-Oncology, Dan L. Duncan Cancer Center (GNA, MMG, AAB, ST, YL, SEP, CCL, DWP, MLB) and Department of Neurosurgery (AJ), Baylor College of Medicine, Houston, TX; Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT (EBC); Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA (EBC); Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH (JBS); Department of Epidemiology and Biostatistics, Georgia State University School of Public Health, Atlanta, GA (DI); Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC (DI, JS); Department of Surgery, Duke University Medical Center, Durham, North Carolina (FAO); Cancer and Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Tel Hashomer (SS); Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel (SiS); Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark (CJ); Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK (RSH); Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN (RBJ, DL); Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY (SHO, JLB); Department of Neurology, NorthShore University HealthSystem, Evanston, IL (RTM); Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA (MRW, KMW); Department of Public Health Services, University of Alberta, Edmonton, Alberta, Canada (FGD); Departments of Neurology, Neurosurgery, and Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA (RL); Department of Biostatistics (Sa

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju384DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296199PMC
January 2015

RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.

Lancet Oncol 2014 Dec 17;15(13):1469-1480. Epub 2014 Nov 17.

Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)71113-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559342PMC
December 2014

The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.

Nat Commun 2014 Nov 21;5:5383. Epub 2014 Nov 21.

1] Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, 413 East 69th Street, Room 1402, New York, New York 10021, USA [2] Institute for Precision Medicine, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms6383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241506PMC
November 2014

Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.

Neuro Oncol 2014 Oct 9;16(10):1333-40. Epub 2014 Apr 9.

Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden (U.A., C.W., B.S.M.); Computational Life Science Cluster (CLiC), Umeå University, Umeå, Sweden (C.W.); Department of Medical Biosciences, Pathology, Umeå University, Umeå Sweden (K.C.); Department of Oncology, Clinical Science, Lund University, Lund, Sweden (S.A., Å.B.); Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine, Houston, Texas (G.N.A., M.L.B.); Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas (S.S.); Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, Texas (C.C.L.); Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas (M.N.B.); School of Public Health, Yale University, New Haven, Connecticut (E.B.C.); Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts (E.B.C.); Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (J.B.-S.); University of Southern California, Los Angeles, California (R.L.); Cancer Control and Prevention Program/Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina (D.I., J.S.); Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK (R.S.H.); Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center , New York, New York (J.L.B., S.H.O.); Mayo Comprehensive Clinic Cancer, Mayo Clinic, Rochester, Minnesota (R.B.J., D.H.L.); Department of Neurological Surgery, University of California, San Francisco, California (M.W.); School of Public Health, University of Alberta, Edmonton, Canada (F.G.D.); Department of Neurology, NorthShore University Health System, Evanston, Illinois (R.M.); Cancer Late Effects Research, Oncology, Finsencenteret, Rigshospitalet, University of Copenhagen and Head, Survivorship, Danish Cancer Society Research Center, Copenhagen, Denmark (C.J.)

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nou052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165415PMC
October 2014

Effective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brain.

Mol Ther 2014 Mar 26;22(3):547-553. Epub 2013 Dec 26.

Center for Advanced Biotechnology and Medicine, Piscataway, New Jersey, USA; Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2013.267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944336PMC
March 2014

Tumorgrafts as in vivo surrogates for women with ovarian cancer.

Clin Cancer Res 2014 Mar 7;20(5):1288-97. Epub 2014 Jan 7.

Authors' Affiliations: Departments of Oncology, Radiation Oncology, and Molecular Pharmacology and Experimental Therapeutics; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics; Division of Gynecologic Surgery; Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Women's Cancer Program, Samuel Oschin Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2611DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947430PMC
March 2014

Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.

J Clin Oncol 2014 Mar 10;32(8):783-90. Epub 2014 Feb 10.

J. Gregory Cairncross, University of Calgary, Calgary, Alberta; Luis Souhami, McGill University, Montreal, Quebec; Normand J. Laperriere, University of Toronto, Toronto, Ontario, Canada; Meihua Wang, American College of Radiology, Philadelphia, PA; Robert B. Jenkins, Caterina Giannini, and Jan C. Buckner, Mayo Clinic, Rochester, MN; Edward G. Shaw, Wake Forest School of Medicine, Winston-Salem, NC; David G. Brachman, Arizona Oncology Services Foundation/Barrow Neurological Institute, Phoenix, AZ; Karen L. Fink, Baylor University, Dallas, TX; Jason T. Huse, Memorial Sloan-Kettering Cancer Center, New York, NY; Minesh P. Mehta, Northwestern University, Chicago, IL; and Walter J. Curran Jr, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.3726DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940537PMC
March 2014

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

J Clin Oncol 2013 Nov 7;31(31):3997-4013. Epub 2013 Oct 7.

Antonio C. Wolff, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore; Lisa M. McShane, National Cancer Institute, Bethesda, MD; M. Elizabeth H. Hammond, University of Utah School of Medicine and Intermountain Healthcare, Salt Lake City, UT; David G. Hicks, University of Rochester Medical Center, Rochester, NY; Mitch Dowsett, Royal Marsden Hospital, London, United Kingdom; Kimberly H. Allison, Stanford University Medical Center, Stanford; Patrick Fitzgibbons, St Jude Medical Center, Fullerton; Michael F. Press, University of Southern California, Los Angeles, CA; Donald C. Allred, Washington University School of Medicine, St Louis, MO; John M.S. Bartlett, Ontario Institute for Cancer Research; Wedad Hanna, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; Michael Bilous, University of Western Sydney and Healthscope Pathology, Sydney, New South Wales, Australia; Robert B. Jenkins, Mayo Clinic, Rochester, MN; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Patricia A. Spears, North Carolina State University, Raleigh, NC; Gail H. Vance, Indiana University Medical Center, Indianapolis, IN; Giuseppe Viale, University of Milan, European Institute of Oncology, Milan, Italy; and Daniel F. Hayes, University of Michigan Comprehensive Cancer Care Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.9984DOI Listing
November 2013